InBody Band 3 Fitness Tracker to Improve Health Outcomes and Quality of Life in Black Prostate Cancer Survivors
NCT ID: NCT06703996
Last Updated: 2025-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2024-11-04
2025-05-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)
NCT02730338
Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE Trial
NCT05918263
Digitally Captured Activity Data and PROs to Monitor Physical Function in Prostate Cancer Patients
NCT04575402
Together Stronger: A Family-centered Lifestyle Intervention for Black Prostate Cancer Survivors and Their Caregivers
NCT07164456
Body Composition Post Cancer Treatment
NCT03690401
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Assess the feasibility of a remote wearables-based intervention among Black prostate cancer survivors.
II. Assess the acceptability of the wearables-based intervention among Black prostate cancer survivors.
OUTLINE:
Patients wear the InBody Band 3 fitness tracker continuously and participate in check-in/goal-setting discussions over 20-30 minutes weekly for 6 weeks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supportive care (InBody Band 3 fitness tracker)
Patients wear the InBody Band 3 fitness tracker continuously and participate in check-in/goal-setting discussions over 20-30 minutes weekly for 6 weeks.
Discussion
Participate in check-in/goal-setting discussions
Medical Device Usage and Evaluation
Wear the InBody Band 3 fitness tracker
Questionnaire Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Discussion
Participate in check-in/goal-setting discussions
Medical Device Usage and Evaluation
Wear the InBody Band 3 fitness tracker
Questionnaire Administration
Ancillary studies
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age or older
* Self-identify as Black
* Have been diagnosed with stage I-IV prostate cancer
* Have an active email address and are able to regularly check emails for electronic surveys
* Own and are willing to use a personal smartphone with regular/reliable access to the internet to sync regularly with a fitness tracker
* Are willing to wear and use a smart fitness tracker for 6 weeks and allow sharing of their fitness data with the study team
* Are not currently undergoing adjunct cancer therapy (e.g. chemotherapy, radiation) during the 6 weeks of study participation, except oral tyrosine kinase inhibitor or hormonal therapies; and
* Are an existing Mayo patient
* Self-report that they would like to improve their physical activity during initial study coordinator contact
Exclusion Criteria
* Have an implanted medical device (e.g., pacemaker, etc.) or a life-sustaining device (e.g., patient monitoring device)
* Have a self-reported history of a psychiatric disorder(s) or moderate to severe cognitive impairment precluding participation in the study intervention or preventing the ability to provide independent informed consent
* Are on prolonged bed rest (i.e., more than half of the waking day in bed) by self-report
* Currently have any lower extremity injury that impedes them from engaging in walking for one block
* Are unable to walk for at least one block without a walking aide by self-report; or
* Regularly use a wheelchair for mobility by self-report
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emma Fortune Ngufor
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emma Fortune Ngufor, PhD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic in Rochester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Florida
Jacksonville, Florida, United States
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2024-09282
Identifier Type: REGISTRY
Identifier Source: secondary_id
24-009203
Identifier Type: OTHER
Identifier Source: secondary_id
24-009203
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.